Biotech · Public company · Brisbane, CA, US

Vera Therapeutics, Inc.

Ticker VERA · SEC CIK 0001831828

Track this companyFree. Adds Vera Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials64 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

Atacicept in Multiple Glomerular DiseasesPHASE2 · RECRUITING · started Jul 7, 2025ClinicalTrials.gov NCT06983028 · fetched Nov 12, 2026
Monthly Dosing of Atacicept in IgANPHASE2 · ACTIVE_NOT_RECRUITING · started May 29, 2025ClinicalTrials.gov NCT07020923 · fetched Nov 12, 2026
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptPHASE2 · ENROLLING_BY_INVITATION · started Dec 1, 2024ClinicalTrials.gov NCT06674577 · fetched Nov 12, 2026
Atacicept in Subjects With IgA NephropathyPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 29, 2023ClinicalTrials.gov NCT04716231 · fetched Nov 12, 2026
Atacicept in Subjects With Active Lupus Nephritis (COMPASS)PHASE3 · WITHDRAWN · started Nov 2, 2022ClinicalTrials.gov NCT05609812 · fetched Nov 12, 2026
A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant RecipientsPHASE2 · COMPLETED · started Aug 5, 2020ClinicalTrials.gov NCT04294472 · fetched Nov 12, 2026